Author:
Sassi Angelina,Lestari Bony Wiem,El Muna Kuuni Ulfah Naila,Oga-Omenka Charity,Afifah Nur,Widarna Rodiah,Huria Lavanya,Aguilera Vasquez Nathaly,Benedetti Andrea,Hadisoemarto Panji Fortuna,Daniels Benjamin,Das Jishnu,Pai Madhukar,Alisjahbana Bachti
Abstract
Abstract
Background
Indonesia has the second highest incidence of tuberculosis in the world. While 74% of people with tuberculosis in Indonesia first accessed the private health sector when seeking care for their symptoms, only 18% of tuberculosis notifications originate in the private sector. Little is known about the impact of the COVID-19 pandemic on the private sector. Using unannounced standardized patient visits to private providers, we aimed to measure quality of tuberculosis care during the COVID-19 pandemic.
Methods
A cross-sectional study was conducted using standardized patients in Bandung City, West Java, Indonesia. Ten standardized patients completed 292 visits with private providers between 9 July 2021 and 21 January 2022, wherein standardized patients presented a presumptive tuberculosis case. Results were compared to standardized patients surveys conducted in the same geographical area before the onset of COVID-19.
Results
Overall, 35% (95% confidence interval (CI): 29.2–40.4%) of visits were managed correctly according to national tuberculosis guidelines. There were no significant differences in the clinical management of presumptive tuberculosis patients before and during the COVID-19 pandemic, apart from an increase in temperature checks (adjusted odds ratio (aOR): 8.05, 95% CI: 2.96–21.9, p < 0.001) and a decrease in throat examinations (aOR 0.16, 95% CI: 0.06–0.41, p = 0.002) conducted during the pandemic.
Conclusions
Results indicate that providers successfully identify tuberculosis in their patients yet do not manage them according to national guidelines. There were no major changes found in quality of tuberculosis care due to the COVID-19 pandemic. As tuberculosis notifications have declined in Indonesia due to the COVID-19 pandemic, there remains an urgent need to increase private provider engagement in Indonesia and improve quality of care.
Funder
Bill and Melinda Gates Foundation
University of Padjadjaran
Publisher
Springer Science and Business Media LLC
Reference46 articles.
1. World Health Organization. Global tuberculosis report 2022. Geneva: World Health Organization; 2022. Available from: https://www.who.int/publications-detail-redirect/9789240061729. Cited 2022 Nov 9.
2. Caren GJ, Iskandar D, Pitaloka DAE, Abdulah R, Suwantika AA. COVID-19 pandemic disruption on the management of tuberculosis treatment in Indonesia. J Multidiscip Healthc. 2022;15:175–83.
3. Martin-Hughes R, Vu L, Cheikh N, Kelly SL, Fraser-Hurt N, Shubber Z, et al. Impacts of COVID-19-related service disruptions on TB incidence and deaths in Indonesia, Kyrgyzstan, Malawi, Mozambique, and Peru: implications for national TB responses. PLOS Glob Public Health. 2022;2(3):e0000219.
4. Downey LE, Gadsden T, Vilas VDR, Peiris D, Jan S. The impact of COVID-19 on essential health service provision for endemic infectious diseases in the South-East Asia region: a systematic review. Lancet Reg Health Southeast Asia. 2022;1. Available from: https://www.thelancet.com/journals/lansea/article/PIIS2772-3682(22)00011-7/fulltext. Cited 2022 Sep 7.
5. Mahendradhata Y, Andayani NLPE, Marthias T. COVID-19 health system response monitor: Republic of Indonesia. New Delhi: World Health Organization Regional Office for South-East Asia; 2021.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献